Ibuprofen Extended-Release NDA Slated For 2005, SCOLR Pharma Says
This article was originally published in The Tan Sheet
Executive Summary
SCOLR Pharma plans to file an NDA in summer 2005 for CDT extended-release 12-hour ibuprofen tablets, the firm announced July 26
You may also be interested in...
SCOLR May File NDA For Ibuprofen Product Following Break With Wyeth
SCOLR Pharma will either file an NDA with FDA or work with another pharmaceutical company to develop its 12-hour extended-release ibuprofen product after Wyeth announced it will terminate an agreement with the firm effective April 16
SCOLR May File NDA For Ibuprofen Product Following Break With Wyeth
SCOLR Pharma will either file an NDA with FDA or work with another pharmaceutical company to develop its 12-hour extended-release ibuprofen product after Wyeth announced it will terminate an agreement with the firm effective April 16
SCOLR May File NDA For Ibuprofen Product Following Break With Wyeth
SCOLR Pharma will either file an NDA with FDA or work with another pharmaceutical company to develop its 12-hour extended-release ibuprofen product after Wyeth announced it will terminate an agreement with the firm effective April 16